Drug recall: Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 mg, 60 Tablets per Bottle, Rx only, Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA. NDC: 00597-0300-45
Official structured record identifier: 99233.
Publisher
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- openFDA Drug Recalls
- Region
- USA
- Scope
- Regulatory
- Published
- July 8, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
Official structured record identifier: 99233.
Source route
Continue on open.fda.gov
Leave the platform to read the original full article on the publisher site.
Source: openFDA Drug Recalls
Scope: Regulatory
Related coverage
More related coverage
Drug label update: Acetaminophen Extra Strength
Official structured record identifier: 9d34abc2-3a9a-b68f-80d4-4ede1eb1e45f.
Drug label update: Allergy Relief
Official structured record identifier: 44da36d2-1881-e779-d3a2-13ea828f9240.
Unpaid carers action plan: recognise, refer, reach
This action plan aims to improve the lives of unpaid carers in England.
SaBTO reports and guidance documents
Reports published by the advisory committee on the Safety of Blood, Tissues and Organs (SaBTO).